This advanced diagnostic procedure involves analyzing the breakdown products, or metabolites, of key hormones in biological fluids such as urine, saliva, or blood, rather than just the parent hormones themselves. This screening provides a detailed, dynamic view of how the body is processing and clearing hormones, offering critical insight into metabolic pathways that affect health and disease risk. It moves beyond simple concentration levels to assess the complete hormonal lifecycle.
Origin
The technique is an evolution of traditional endocrinology, driven by advances in mass spectrometry and chromatography. While initial hormone testing focused on circulating levels, the concept of metabolite screening gained prominence from toxicology and functional medicine, recognizing that the pathways of hormone breakdown are as important as their production.
Mechanism
The screening quantifies specific metabolites, such as the various forms of estrogen metabolites (e.g., 2-OH, 4-OH, 16-OH) or androgen metabolites (e.g., androsterone, etiocholanolone). These profiles reveal the efficiency of phase I and phase II liver detoxification, indicating whether hormones are being metabolized down protective or potentially harmful pathways. This detailed mechanistic understanding guides precise nutritional and clinical interventions to optimize detoxification and balance.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.